ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,715
0,10%
Bitcoin
58 841,74
-0,47%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Vir Biotechnology Inc (VIR)

  7. Vir Biotechnology Inc (VIR) Actualités

VIR Vir Biotechnology Inc

9,46
0,72 (8,24%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Vir Biotechnology Inc VIR NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,72 8,24% 9,46 01:53:44
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
8,91 8,745 9,20 9,18 8,74
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202422:05BWVir Biotechnology Provides Corporate Update and Reports..
30/4/202422:05BWVir Biotechnology to Participate in the BofA Securities..
18/4/202414:00BWVir Biotechnology Announces Nomination of Norbert..
11/4/202422:30BWVir Biotechnology to Provide Business Update and Report..
05/3/202414:05BWVir Biotechnology Completes Enrollment of Phase 2 Chronic..
27/2/202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202401:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202422:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/2/202414:05BWVir Biotechnology to Participate in Upcoming Investor..
22/2/202422:12EDGAR2Form 8-K - Current report
22/2/202422:05BWVir Biotechnology Provides Corporate Update and Reports..
20/2/202422:33EDGAR2Form 8-K - Current report
20/2/202422:30BWVir Biotechnology Announces Dr. Phil Pang Will Step Down as..
17/2/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202422:05BWVir Biotechnology to Provide Business Update and Report..
03/1/202420:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202311:59IHMARKETNEWSApple Stocks Reach Record, Adobe Faces Stock Drops,..
13/12/202322:06EDGAR2Form 8-K - Current report
13/12/202322:05BWVir Biotechnology Announces Strategic Steps to Reduce..
06/12/202322:05BWVir Biotechnology to Present at J.P. Morgan 2024 42nd Annual..
13/11/202314:00BWVir Biotechnology to Present New Data from Its Ongoing Phase..
10/11/202314:00BWVir Biotechnology to Present Late-Breaking Data from Its..
08/11/202314:05BWVir Biotechnology Ranked the Fastest-Growing Company in..
03/11/202321:37EDGAR2Form 8-K - Current report
03/11/202321:33EDGAR2Form S-3ASR - Automatic shelf registration statement of..
03/11/202321:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:09EDGAR2Form 8-K - Current report
02/11/202321:05BWVir Biotechnology Provides Corporate Update and Reports..
30/10/202313:00BWVir Biotechnology Appoints Jennifer Towne, Ph.D., as..
12/10/202322:05GLOBEVir Biotechnology to Participate in the H.C. Wainwright 4th..
11/10/202314:00GLOBEVir Biotechnology Announces Multiple Abstracts Highlighting..
05/10/202322:30GLOBEVir Biotechnology to Provide Business Update and Report..
03/10/202314:01EDGAR2Form 8-K - Current report
03/10/202313:59GLOBEVir Biotechnology Awarded BARDA Funding to Support..
20/9/202314:00GLOBEVir Biotechnology Announces First Participant Dosed in New..
20/9/202312:02EDGAR2Form 8-K - Current report
29/8/202322:30GLOBEVir Biotechnology to Participate in Upcoming Investor..
04/8/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:14EDGAR2Form 8-K - Current report
03/8/202322:05GLOBEVir Biotechnology Provides Corporate Update and Reports..
26/7/202322:05GLOBEVir Biotechnology to Provide Business Update and Report..
20/7/202314:04EDGAR2Form 8-K - Current report
20/7/202314:00GLOBEVir Biotechnology Announces Topline Data from Phase 2..
06/7/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/7/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202323:01EDGAR2Form 144 - Report of proposed sale of securities

Dernières Valeurs Consultées

NASDAQ
VIR
Vir Biotechnology
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés